Last reviewed · How we verify

Neuraxial Analgesia

Jennifer Holder-Murray · Phase 3 active Small molecule

Neuraxial Analgesia is a Small molecule drug developed by Jennifer Holder-Murray. It is currently in Phase 3 development for Pain management during childbirth, Postoperative pain management. Also known as: Intrathecal morphine/hydromorphone, IT morphine/hydromorphine.

Neuraxial analgesia involves the administration of medications directly into the spinal fluid to block pain signals to the brain.

Neuraxial analgesia involves the administration of medications directly into the spinal fluid to block pain signals to the brain. Used for Pain management during childbirth, Postoperative pain management.

At a glance

Generic nameNeuraxial Analgesia
Also known asIntrathecal morphine/hydromorphone, IT morphine/hydromorphine
SponsorJennifer Holder-Murray
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

This approach targets the spinal cord and its associated nerve endings to provide localized pain relief. Neuraxial analgesia can be achieved through various routes, including epidural, spinal, and combined spinal-epidural administration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Neuraxial Analgesia

What is Neuraxial Analgesia?

Neuraxial Analgesia is a Small molecule drug developed by Jennifer Holder-Murray, indicated for Pain management during childbirth, Postoperative pain management.

How does Neuraxial Analgesia work?

Neuraxial analgesia involves the administration of medications directly into the spinal fluid to block pain signals to the brain.

What is Neuraxial Analgesia used for?

Neuraxial Analgesia is indicated for Pain management during childbirth, Postoperative pain management.

Who makes Neuraxial Analgesia?

Neuraxial Analgesia is developed by Jennifer Holder-Murray (see full Jennifer Holder-Murray pipeline at /company/jennifer-holder-murray).

Is Neuraxial Analgesia also known as anything else?

Neuraxial Analgesia is also known as Intrathecal morphine/hydromorphone, IT morphine/hydromorphine.

What development phase is Neuraxial Analgesia in?

Neuraxial Analgesia is in Phase 3.

What are the side effects of Neuraxial Analgesia?

Common side effects of Neuraxial Analgesia include Hypotension, Headache, Nausea and vomiting, Itching, Respiratory depression.

Related